Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Whats New LAL-D

    Launch of LAL-D Knowledge Centre

    A new educational resource on lysosomal acid lipase deficiency is
    now available to epgonline.org users. Content highlights include latest
    disease awareness facts and statistics, important treatment information and
    a video channel comprising expert discussions on topics such
    as diagnostic approach and current prognosis.

  • ,CSU news case studies 2016

    Updates to the Chronic Spontaneous
    Urticaria Knowledge Centre

    Case studies from urticaria experts Professor Christian Vestergaard
    and Professor Torsten Zuberbier have been added to the ‘Case Studies
    section of the Chronic Spontaneous Urticaria Knowledge Centre.
    Additionally, this resource has been updated with information
    on the TARGET My Hives app and refreshed with a whole new look and feel.

  • ,OAC Reversal Whats New 2

    Launch of Oral Anticoagulation Reversal Knowledge Centre

    This new resource provides healthcare professionals with accurate information on the approaches
    to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding,
    or require surgery. View illustrated and referenced sections on management of bleeding, oral
    anticoagulants, symposium highlights, key publications commentary and more. This resource is
    developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with
    content provided by CSL Behring.

    This resource is not intended for healthcare professionals outside Europe.

  • ,Hypogonadism Relaunch Whats New

    Launch of updated Hypogonadism Knowledge Centre

    Our Hypogonadism Knowledge Centre contains important disease awareness
    information to support healthcare professionals in the current best practice
    treatment and management of male hypogonadism and is available to access free of
    charge. Sections cover epidemiology, pathophysiology, signs and symptoms, treatment
    options, as well as useful resources and a regularly updated publications digest.

    G.MKT.GM.MH.01.2016.0364

  • ,Cystic Fibrosis Knowledge Centre

    Launch of the Cystic Fibrosis Knowledge Centre

    This new resource has been developed to support healthcare professionals
    in the treatment of patients with cystic fibrosis (CF).
    It contains a host of clinical information including a disease awareness section,
    emerging and supportive therapeutic options and current best practice
    based on recently updated guidelines by the
    European Cystic Fibrosis Society (ECFS).

Latest News

FDA approves Adlyxin (lixisenatide) once-daily GLP-1 receptor agonist to treat type 2 diabetes.-Sanofi

29-Jul-2016

Sanofi announced that the FDA approved Adlyxin (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. The approval of Adlyxin was based on ...

Tokai Pharma discontinues Phase III comparison trial of galeterone to enzalutamide in castration resistant prostate cancer.

28-Jul-2016

Tokai Pharmaceuticals Inc. announced that it plans to discontinue the ARMOR3-SV clinical trial, the company’s pivotal Phase III study comparing galeterone to enzalutamide (Xtandi) in treatment-naïve metastatic castration-resistant prostate cancer ...

FDA no longer requires abuse potential studies for Xadago (safinamide) to treat Parkinsons Disease and Newron will resubmit its NDA to the FDA.

28-Jul-2016

Newron and its partners Zambon S.p.A. and US WorldMeds announced that the FDA and the Controlled Substance Staff (CSS) in the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration no longer require Newron to perform ...

Phase III study of Afstyla [Antihemophilic Factor (Recombinant), Single Chain]shows efficacy in haemophilia- CSL Behring

28-Jul-2016

CSL Behring has presented data from a Phase III pivotal study of Afstyla [Antihemophilic Factor (Recombinant), Single Chain] in hemophilia A patients less than 12 years of age at the XXXII International Congress of the World Federation of Hemophilia ...

Mixed results in Phase III trial of LMTX, a tau aggregation inhibitor, to treat Alzheimer's disease.- TauRx Therapeutics

28-Jul-2016

TauRx Therapeutics Ltd today announced Phase III clinical trial results that show treatment with LMTX, the company's novel tau aggregation inhibitor, had a marked beneficial effect on key measures of Alzheimer's disease in patients with mild or ...

FDA issues safety warning relating to fluoroquinolone antibiotics.

28-Jul-2016

The FDA has approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients with less serious ...

Phase III trial of Adynovate (recombinant factor VIII) meets primary endpoint in haemophilia- Baxalta/Shire

28-Jul-2016

Data is being presented from a global, open-label Phase III study designed to assess the safety and efficacy of a twice-weekly prophylactic Adynovate (recombinant factor VIII), from Baxalta ( now Shire), regimen to control bleeding in ...

Recent Updates

Drugs

Clinical Guidelines

2016 European Guidelines on cardiovascular disease prevention in clinical practice

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

EASL Clinical Practice Guidelines on the management of benign liver tumours

EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones

Medical Journals

Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis.

Hypothyroidism and obesity: An intriguing link.

Canakinumab for the treatment of active systemic juvenile idiopathic arthritis.

Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages

News

News

News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors